Prolia (denosumab; Amgen) is now indicated for use in men with osteoporosis. In addition, the summary of product characteristics has been updated to include abdominal pain as a common adverse reaction.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20065594
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com